Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

US Patent 8133884 · Granted Mar 13, 2012

Estimated economic value: $240,535,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human CD47-targeting single-domain antibody and use thereof2025
Use of exosome derived from decidual natural killer (dNK) cells or dNK cell subs2025
Substituted bicyclic compounds useful as T cell activators2024
Substituted bicyclic compounds useful as T cell activators2024
Substituted bicyclic compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted naphthyridinone compounds useful as T cell activators2023
Substituted naphthyridinone compounds useful as T cell activators2023